GSK got rich, kids got sick, when asthma inhaler was scrapped, Hassan report says

By: Maureen Milliken

Outlets: Manchester InkLink

Published: March 16, 2026

Words: 1,900

Last Updated: 4 days, 13 hours ago

Body Text Preview

WASHINGTON, D.C. – There are few things as burned into Alia Hayes’ memory as the sound of her son’s struggle to breathe.

Her son, Burton, has asthma, and one of the worst nights of that “dreaded dangerous sound” came three years ago and rang the alarm for what became a frightening trip to the hospital.

It didn’t have to happen. The family had used the Flovent HFA inhaler, produced by GlaxoSmithKline, …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

Email Us